Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
As of April 10, 2026, ENDRA Life Sciences Inc. (NDRA) is trading at $4.95, marking a 6.78% decline in recent trading activity. This analysis evaluates key technical levels, prevailing market context, and potential near-term price scenarios for the life sciences stock. No recent earnings data is available for NDRA as of the current date, so this assessment focuses primarily on market sentiment and technical price action rather than fundamental corporate performance metrics. There are no material
Is ENDRA Life (NDRA) Stock Good for Portfolio | Price at $4.95, Down 6.78% - Institutional Grade Stocks
NDRA - Stock Analysis
4855 Comments
609 Likes
1
Karleah
Insight Reader
2 hours ago
Anyone else watching without saying anything?
👍 262
Reply
2
Lylybell
Power User
5 hours ago
Volatility remains part of the market landscape, emphasizing the importance of strategic allocation.
👍 247
Reply
3
Mee
Influential Reader
1 day ago
Who else is following this closely?
👍 56
Reply
4
Ashdon
Returning User
1 day ago
This gave me unnecessary confidence.
👍 23
Reply
5
Uarda
Trusted Reader
2 days ago
A bit frustrating to see this now.
👍 253
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.